Text Size
Trial record 4 of 273 for:    "Breast Neoplasms, Male"
Previous Study | Return to List | Next Study

Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Summa Health System
ClinicalTrials.gov Identifier:
NCT00773669
First received: October 15, 2008
Last updated: July 20, 2011
Last verified: July 2011
History of Changes
  Purpose

The primary goal of this retrospective study is to evaluate the male breast cancer patient population at Summa Health System/Akron City Hospital over a period of 18 years and compare the findings to historical data.

The objectives are to:

  • identify risk factors.
  • evaluate stage and histology at the time of presentation.
  • document treatment modalities and outcomes.
  • analyze outcomes for comparison to historical data.

Condition
Breast Cancer

Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Retrospective
Official Title: Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Summa Health System:

Primary Outcome Measures:
  • Retrospective chart review to evaluate the male breast cancer patient population at Summa Health System/Akron City Hospital over a period of years and compare the findings to historical data. [ Time Frame: Chart review from 1995-2007 ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: October 2008
Estimated Study Completion Date: December 2011
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Males with breast cancer.

Criteria

Inclusion Criteria:

  • Male breast cancer patients diagnosed and/or treated at Summa Health System/Akron City Hospital from the reference year of 1995 through 2007.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00773669

Sponsors and Collaborators
Summa Health System
Investigators
Principal Investigator: Gary Williams, MD Summa Health System
  More Information

No publications provided

Responsible Party: Gary Williams, MD, Summa Health System
ClinicalTrials.gov Identifier: NCT00773669     History of Changes
Other Study ID Numbers: Male Breast Cancer
Study First Received: October 15, 2008
Last Updated: July 20, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Summa Health System:
male breast cancer
Male breast cancer patients diagnosed and/or
treated at Summa Health System/Akron City Hospital
from the reference year of 1995 through 2007.

Additional relevant MeSH terms:
Breast Neoplasms
Breast Neoplasms, Male
Neoplasms by Site
 Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on May 22, 2013